학술논문
Safety of specifically targeting interleukin-13 with tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase III and phase II trials
Document Type
Journal
Source
Subject
Language
English
ISSN
13652133